You can make a case both ways that this extra revi
Post# of 145703
Here’s an extra thought...
What if the reason the fda flip flopped about this type A meeting and went from written to a physical (likely virtual, I don’t recall) meeting is because Cytodyn is moving toward a deal with the UK and the fda realizes it needs to stop f’ing around and start working with us before there’s no vials available in 2020?
For the record I don’t think it’s the case, but the timing is interesting.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)